We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-13.05%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$287B
AUM Growth
-$45.4B
Cap. Flow
+$4.91B
Cap. Flow %
1.71%
Top 10 Hldgs %
16.91%
Holding
3,742
New
162
Increased
2,018
Reduced
1,243
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 19.98%
2 Healthcare 13.1%
3 Financials 12.8%
4 Consumer Discretionary 9.34%
5 Industrials 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORN icon
3426
Orion Group Holdings
ORN
$387M
$39K ﹤0.01%
+16,674
New +$42.9K
TRVN
3427
DELISTED
Trevena, Inc.
TRVN
$39K ﹤0.01%
150
-622
-81% -$137K
DARE icon
3428
Dare Bioscience
DARE
$18.6M
$38K ﹤0.01%
2,544
RCAT icon
3429
Red Cat Holdings
RCAT
$1.12B
$38K ﹤0.01%
18,398
AXLA
3430
DELISTED
Axcella Health Inc. Common Stock
AXLA
$38K ﹤0.01%
+730
New +$35.9K
CDZI icon
3431
Cadiz
CDZI
$264M
$37K ﹤0.01%
15,822
-31,001
-66% -$64.6K
CRDF icon
3432
Cardiff Oncology
CRDF
$66.2M
$37K ﹤0.01%
16,399
-86,744
-84% -$145K
CBIO
3433
Crescent Biopharma
CBIO
$555M
$37K ﹤0.01%
+604
New +$44.7K
CYPH
3434
Cypherpunk Technologies Inc
CYPH
$66.6M
$37K ﹤0.01%
3,200
PTN
3435
Palatin Technologies
PTN
$13.9M
$37K ﹤0.01%
+103
New +$47.5K
CTSO icon
3436
Cytosorbents Corp
CTSO
$22M
$36K ﹤0.01%
15,994
-89,699
-85% -$206K
FLNT
3437
Fluent
FLNT
$104M
$36K ﹤0.01%
5,035
-15,728
-76% -$131K
QMCO icon
3438
Quantum Corp
QMCO
$443M
$36K ﹤0.01%
1,261
-6,467
-84% -$245K
TRVI icon
3439
Trevi Therapeutics
TRVI
$2.61B
$36K ﹤0.01%
+12,557
New +$30.8K
ONCT
3440
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$36K ﹤0.01%
1,612
-3,079
-66% -$68.7K
OTIC
3441
DELISTED
Otonomy, Inc.
OTIC
$36K ﹤0.01%
16,843
CKPT
3442
DELISTED
Checkpoint Therapeutics
CKPT
$35K ﹤0.01%
3,371
ETON icon
3443
Eton Pharmaceutcials
ETON
$1.34B
$35K ﹤0.01%
+13,239
New +$44.4K
LVO icon
3444
LiveOne
LVO
$61.6M
$35K ﹤0.01%
3,979
-8,630
-68% -$70.8K
OESX icon
3445
Orion Energy Systems
OESX
$40.3M
$35K ﹤0.01%
+1,699
New +$41.8K
OGEN icon
3446
Oragenics
OGEN
$2.21M
$35K ﹤0.01%
+56
New +$32.3K
SND icon
3447
Smart Sand
SND
$179M
$35K ﹤0.01%
17,439
TECX
3448
Tectonic Therapeutic
TECX
$538M
$35K ﹤0.01%
3,103
-3,907
-56% -$46.1K
EMKR
3449
DELISTED
Emcore Corp
EMKR
$35K ﹤0.01%
1,115
-8,157
-88% -$275K
AAOI icon
3450
Applied Optoelectronics
AAOI
$7.23B
$34K ﹤0.01%
+21,899
New +$53.6K

Similar funds

Charles Schwab's Q2 2022 Portfolio in Review

As of Q2 2022, Charles Schwab held 3,742 positions worth $287B, down 14% from $333B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q2 2022 filing shows 162 new, 2,018 increased, 1,243 reduced and 206 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M. The largest sale was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $454M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Charles Schwab's largest Q2 2022 buy was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M.
  • Charles Schwab added most to Cisco in Q2 2022, an estimated $554M increase.
  • Charles Schwab's biggest Q2 2022 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $454M.
  • Charles Schwab fully exited Cerner Corp in Q2 2022, selling an estimated $140M.
  • Charles Schwab's ten largest holdings make up 17% of its $287B portfolio in Q2 2022.
  • Charles Schwab opened 162 new positions and closed 206 in Q2 2022.
  • Charles Schwab's portfolio value fell 14% quarter-over-quarter to $287B.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.